MET and ovarian cancer: Furthermore, evaluation of tissue arrays prepared using tumors from ovarian cancer patients, found that the samples which express high levels of ERBB3, also express high levels of Met [a.k.a. MET or hepatocyte growth factor receptor (HGFR)] receptors.